An interventional study of Incisional hernia repair in Incisional Hernia, sponsored by Clayton Petro. Recruiting at 5 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Clayton Petro · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Incisional Hernia with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Incisional Hernia · United States.
Among the 34 studies in Incisional Hernia with a site in United States, this one is the 6th largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2022, is one of 17 with no phase, and was the 27th registered.
212 studies on the registry are indexed under Incisional Hernia; 58 are open to participants now.
Browse Incisional Hernia studies →6 of the 34 studies in Incisional Hernia with a site in United States are open now. Recruiting first, the newest first:
The Cleveland Clinic · Sites in United States
Ages 18+
W.L.Gore & Associates · Sites in United States
Ages 18+
Prisma Health-Upstate · Sites in United States
Ages 18+ · Healthy volunteers
University of South Florida · Sites in United States
Ages 18–65
Corewell Health West · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 39 Incisional Hernia studies recruiting now, 28 (72%) set no upper age limit and 2 (5%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 154 is above the median of 110 across 130 interventional studies indexed under Incisional Hernia.
Median enrollment 98 across the 20 interventional studies, 38 across the 14 observational. Of the 24 that completed or were terminated, 9 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 34 have an industry lead sponsor. The 10 most frequent:
Clayton Petro is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Clayton Petro has 1 study filed under Incisional Hernia — fewer than ten, so there is no comparison to draw.
5 of the studies in Incisional Hernia with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04718168W.L.Gore & AssociatesGORE® ENFORM Biomaterial Product Study | 2026-12 |
| NCT06511414Northwestern UniversityEffect of Duramesh™ on Hernia Formation After Ileostomy Closure | 2026-12-01 |
| NCT07874724University of South FloridaCryoneurolysis for Abdominal Wall Relaxation Prior to Ventral Hernia Repair | 2027-03-01 |
| NCT06306976Prisma Health-UpstateShear-Wave Elastography | 2027-07-31 |
| NCT07871630Corewell Health WestPhasix Mesh Underlay During Loop Ileostomy Closure | 2027-10-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 34 studies in Incisional Hernia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this randomized controlled trial is to compare the difference in quality of life at one year postoperatively for patients undergoing incisional hernia repair with mesh versus suture repair using modern techniques.
The main question it aims to answer are:
This is a patient-blinded randomized control trial comparing incisional hernia repair using synthetic mesh versus suture repair. This is a non-inferiority trial theorizing that suture repair will be non-inferior with respect to quality of life (using the HerQLes survey) at 1 year postoperatively. Patients will be blinded to the intervention, groups will be in parallel.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will undergo incisional hernia repair with prolene mesh in the retrorectus position with at least 4cm of overlap.
Procedure: Incisional hernia repair
Participants will undergo incisional hernia repair with suture alone using modern surgical techniques.
Procedure: Incisional hernia repair
Participants will undergo incisional hernia repair
Hernia specific quality of life
Suture repair will be compared to mesh repair for incisional hernias 2-6cm with respect to quality of life using the Hernia-specific Quality of Life (HerQLes) summary score at one year postoperatively. This is reported as a score from 0-100 with higher numbers indicating better quality of life.
Time frame: 1 year
Hernia specific quality of life
Compare HerQLes summary score at baseline, 30-day, and 2-year follow-up, and 5-year follow up
Time frame: 5 years
PROMIS-3a-Pain Intensity scores
Compare PROMIS-3a-Pain Intensity scores (a validated measure of pain) at baseline, 30-day, 1-year, 2 years, and 5- year follow up. Scores are reported as raw values from 3-15 or as T-scores from 30.7-71.8, with higher numbers indicating more pain.
Time frame: 5 years
Recurrence
Compare composite recurrence using clinical, radiographic exam, and Hernia Recurrence Inventory (HRI) at 1-year, and 2-year, and 5 year follow-up postoperatively
Time frame: 5 years
Complications
Compare all complications at 30-day, 1-year, 2-year, and 5-year follow-up postoperatively. This includes occurrence of surgical site infections, surgical site occurrence requiring intervention, readmissions, hernia related reoperation, or mortality.
Time frame: 5 years
Overall quality of life
4\. Compare Euro-QOL-5D-5L with VAS assessment scores at baseline, 30-day, 1-year, 2 years, and 5-year follow-up.
Time frame: 5 years
Cost effectiveness
5\. Perform a formal cost effectiveness analysis utilizing quality adjusted life years and incremental cost effectiveness ratios.
Time frame: 5 years
Started Nov 2022 (actual). Primary completion is estimated for Oct 2028, 71 months after the start.
Of 60 non-industry interventional studies with no phase under Incisional Hernia, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 60. This study's planned 71 months is above that.
Counting every sponsor, half of 67 studies reached it within 43 months; a quarter within 29 and three quarters within 60.
Primary completion moved once since we started tracking on Sep 25, 2026: Oct 2026 → Oct 2028, on Nov 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clayton Petro